Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Mar;76(3):343-8.
doi: 10.1136/jnnp.2003.033530.

Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach

S J G Lewis  1 , T Foltynie, A D Blackwell, T W Robbins, A M Owen, R A Barker
Affiliations

Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach

S J G Lewis et al. J Neurol Neurosurg Psychiatry. 2005 Mar.

Abstract

Objective: To investigate the heterogeneity of idiopathic Parkinson's disease (PD) in a data driven manner among a cohort of patients in the early clinical stages of the disease meeting established diagnostic criteria.

Methods: Data on demographic, motor, mood, and cognitive measures were collected from 120 consecutive patients in the early stages of PD (Hoehn and Yahr I-III) attending a specialist PD research clinic. Statistical cluster analysis of the data allowed the existence of the patient subgroups generated to be explored.

Results: The analysis revealed four main subgroups: (a) patients with a younger disease onset; (b) a tremor dominant subgroup of patients; (c) a non-tremor dominant subgroup with significant levels of cognitive impairment and mild depression; and (d) a subgroup with rapid disease progression but no cognitive impairment.

Conclusions: This study complements and extends previous research by using a data driven approach to define the clinical heterogeneity of early PD. The approach adopted in this study for the identification of subgroups of patients within Parkinson's disease has important implications for generating testable hypotheses on defining the heterogeneity of this common condition and its aetiopathological basis and thus its treatment.

PubMed Disclaimer

Comment in

  • Heterogeneity of Parkinson's disease.
    Schrag A, Quinn NP, Ben-Shlomo Y. Schrag A, et al. J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):275-6. J Neurol Neurosurg Psychiatry. 2006. PMID: 16421140 Free PMC article. No abstract available.

References

    1. Mov Disord. 2003 Mar;18(3):275-9 - PubMed
    1. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4 - PubMed
    1. J Neurosci. 2003 Jul 16;23(15):6351-6 - PubMed
    1. Neurology. 1967 May;17(5):427-42 - PubMed
    1. J Psychiatr Res. 1975 Nov;12(3):189-98 - PubMed

Publication types